[go: up one dir, main page]

AU2001247600A1 - Methods of modulating hair growth - Google Patents

Methods of modulating hair growth

Info

Publication number
AU2001247600A1
AU2001247600A1 AU2001247600A AU4760001A AU2001247600A1 AU 2001247600 A1 AU2001247600 A1 AU 2001247600A1 AU 2001247600 A AU2001247600 A AU 2001247600A AU 4760001 A AU4760001 A AU 4760001A AU 2001247600 A1 AU2001247600 A1 AU 2001247600A1
Authority
AU
Australia
Prior art keywords
methods
hair growth
modulating hair
modulating
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247600A
Inventor
Michael Detmar
Kiichiro Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU2001247600A1 publication Critical patent/AU2001247600A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001247600A 2000-03-31 2001-03-21 Methods of modulating hair growth Abandoned AU2001247600A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19359700P 2000-03-31 2000-03-31
US60193597 2000-03-31
PCT/US2001/008889 WO2001074317A1 (en) 2000-03-31 2001-03-21 Methods of modulating hair growth

Publications (1)

Publication Number Publication Date
AU2001247600A1 true AU2001247600A1 (en) 2001-10-15

Family

ID=22714278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247600A Abandoned AU2001247600A1 (en) 2000-03-31 2001-03-21 Methods of modulating hair growth

Country Status (5)

Country Link
US (1) US6773881B2 (en)
EP (1) EP1267800A4 (en)
JP (1) JP2004500409A (en)
AU (1) AU2001247600A1 (en)
WO (1) WO2001074317A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20020119A1 (en) * 2002-03-05 2003-09-05 Geymonat Spa COMPOSITIONS CONTAINING PLGF FOR PHARMACEUTICAL AND COSMETIC USE.
WO2006121610A2 (en) * 2005-05-05 2006-11-16 Genencor International, Inc. Personal care compositions and methods for their use
EP1750736B1 (en) 2004-01-16 2010-04-21 Cognis France, S.A.S. Uses for the extract of gymnema sylvestris
WO2006026617A2 (en) * 2004-08-30 2006-03-09 Iken Tissue Therapeutics, Inc. Compositions and methods of promoting hair growth
US20070036740A1 (en) * 2004-10-06 2007-02-15 Reed Kenneth C Modulation of hair growth
GB0601684D0 (en) * 2006-01-27 2006-03-08 Reckitt Benckiser Uk Ltd Composition, process for preparation and method of use
GB0612028D0 (en) * 2006-06-16 2006-07-26 Imp Innovations Ltd Bioactive glass
DE102006056664A1 (en) * 2006-11-29 2008-06-05 Henkel Kgaa Use of quercetin
EP2136778A2 (en) * 2007-03-20 2009-12-30 Harold Brem Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
EP2139447A2 (en) 2007-03-20 2010-01-06 Harold Brem Gm-csf cosmeceutical compositions and methods of use thereof
GB0722332D0 (en) * 2007-11-14 2007-12-27 Reckitt Benckiser Uk Ltd Personal care article
TW200927161A (en) * 2007-11-15 2009-07-01 Posh Cosmeceuticals Inc Composition containing granulocyte colony stimulating factor (GCSF) for hair growth
EP2293738A2 (en) * 2008-05-27 2011-03-16 Imperial Innovations Limited Process for producing porous scaffolds from sinterable glass
GB0809592D0 (en) * 2008-05-27 2008-07-02 Imp Innovations Ltd Biomaterials
GB0911365D0 (en) 2009-06-30 2009-08-12 Bioceramic Therapeutics Ltd Multicomponent glasses for use as coatings and in personal care products
AU2013313105B2 (en) * 2012-09-10 2016-07-07 Sun Pharmaceutical Industries, Inc. A method for the permanent removal of hair
EP2735303A1 (en) * 2012-11-23 2014-05-28 Pilosciences Hair growth compositions and methods
US20160250298A1 (en) 2013-11-01 2016-09-01 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
JP7265992B2 (en) * 2017-03-26 2023-04-27 ミノヴィア セラピューティクス リミテッド Mitochondrial compositions and methods for skin and hair treatment
ES2992862T3 (en) 2018-07-22 2024-12-18 Minovia Therapeutics Ltd Mitochondrial augmentation therapy of renal diseases
US12440515B2 (en) 2018-07-22 2025-10-14 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of brain diseases
EP3823641A4 (en) 2018-07-22 2022-05-18 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
MX2021000955A (en) 2018-07-22 2021-05-27 Minovia Therapeutics Ltd Mitochondrial augmentation therapy for primary mitochondrial diseases.
FR3153995A1 (en) * 2023-10-13 2025-04-18 L'oreal Use of urolithin to prevent/slow down hair thinning

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480975A (en) 1994-02-08 1996-01-02 Brigham And Women's Hospital Induction of vascular endothelial growth factor (VEGF) by transition metals
US6159950A (en) * 1998-10-16 2000-12-12 Cornell Research Foundation, Inc. Method of modulating hair growth

Also Published As

Publication number Publication date
EP1267800A1 (en) 2003-01-02
US20020062835A1 (en) 2002-05-30
JP2004500409A (en) 2004-01-08
EP1267800A4 (en) 2004-08-25
WO2001074317A1 (en) 2001-10-11
US6773881B2 (en) 2004-08-10

Similar Documents

Publication Publication Date Title
AU2001247600A1 (en) Methods of modulating hair growth
AU2001229712A1 (en) Reduction of hair growth
AU2001276934A1 (en) Methods of modulating fibrosis
AU4466901A (en) Hair growth or hair formation controlling agents
EP1047420A4 (en) Modulation of hair growth
AU2001289085A1 (en) Antisense modulation of flip-c expression
AU2001277054A1 (en) Antisense modulation of lysophospholipase i expression
AU2001284417A1 (en) Hair growth stimulants
AU9319798A (en) Reduction of hair growth
AU1446300A (en) Method of modulating hair growth
AU2001291019A1 (en) Method of modulating neovascularization
AU2001278338A1 (en) Methods and compositions for modulating tumor growth
AU2001227847A1 (en) Antisense modulation of pepck-cytosolic expression
AU2002320525A1 (en) Antisense modulation of glioma-associated oncogene-2 expression
AU3205801A (en) Method and composition for promoting hair growth
AU2001287136A1 (en) Antisense modulation of glioma-associated oncogene-1 expression
AU2001288093A1 (en) Hair growth stimulant
AU2002224178A1 (en) Use of cyclosporin 7-thioamide derivatives for hair growth
AU2001280588A1 (en) Methods of modulating angiogenesis
AU2001296413A1 (en) Oligonucleotide modulation of her-1 expression
AUPQ904100A0 (en) Method of encryption
AU2003245262A1 (en) Reduction of hair growth
AU2001290792A1 (en) Antisense modulation of madh6 expression
AU2000274825A1 (en) Cosmetic method
AU2002347809A1 (en) Antisense modulation of inhibitor-kappa b kinase-gamma expression